Spruce Biosciences (SPRB) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Spruce Biosciences (SPRB).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | 700K (+16.67%) | 600K (-62.73%) | 1.61M (-19.50%) | 2.00M (-30.80%) | 2.89M (-5.86%) | 3.07M (+41.47%) | 2.17M (+10.71%) | 1.96M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 7.58M (+84.88%) | 4.10M (-18.16%) | 5.01M | -430.00K | 11M (-49.49%) | 21M (+227.63%) | 6.55M (-19.04%) | 8.09M (-21.61%) | 10M (-7.03%) | 11M (-17.72%) | 13M (+2.74%) | 13M (+12.13%) | 12M (+32.47%) | 8.84M (+0.57%) | 8.79M (-2.98%) | 9.06M (+6.46%) | 8.51M (+35.94%) | 6.26M (-27.29%) | 8.61M (-5.59%) | 9.12M (+35.92%) | 6.71M (+15.49%) | 5.81M (-25.23%) | 7.77M (+37.28%) | 5.66M (+22.78%) | 4.61M (-47.07%) | 8.71M (+312.80%) | 2.11M | - | - |
Selling General And Administrative | 4.41M (-37.00%) | 7.00M (+117.39%) | 3.22M (+3.21%) | 3.12M (-14.75%) | 3.66M (+10.57%) | 3.31M (-4.34%) | 3.46M (-2.81%) | 3.56M (-17.59%) | 4.32M (+46.44%) | 2.95M (-8.95%) | 3.24M (+7.64%) | 3.01M (-12.75%) | 3.45M (+5.50%) | 3.27M (+18.05%) | 2.77M (-1.77%) | 2.82M (-12.69%) | 3.23M (+12.15%) | 2.88M (+3.23%) | 2.79M (+7.31%) | 2.60M (-16.13%) | 3.10M (+23.02%) | 2.52M (+40.78%) | 1.79M (+145.21%) | 730K (+40.38%) | 520K (-71.58%) | 1.83M (+297.83%) | 460K | - | - |
Operating Expenses | 12M (+8.02%) | 11M (+34.87%) | 8.23M (+205.95%) | 2.69M (-81.44%) | 14M (-41.50%) | 25M (+147.45%) | 10M (-14.08%) | 12M (-20.42%) | 15M (+4.20%) | 14M (-16.02%) | 17M (+3.66%) | 16M (+6.46%) | 15M (+25.19%) | 12M (+4.76%) | 12M (-2.69%) | 12M (+1.28%) | 12M (+28.34%) | 9.14M (-19.82%) | 11M (-2.65%) | 12M (+19.25%) | 9.82M (+17.75%) | 8.34M (-12.76%) | 9.56M (+49.61%) | 6.39M (+24.56%) | 5.13M (-51.33%) | 11M (+311.72%) | 2.56M | - | - |
Depreciation And Amortization | 250K (+1150.00%) | 20K | - | - | 10K (-66.67%) | 30K | - | - | 20K (-60.00%) | 50K | - | - | 20K (-50.00%) | 40K | - | 10K (-50.00%) | 20K (-60.00%) | 50K | - | 10K (0.00%) | 10K (-75.00%) | 40K | - | - | - | 10K | - | - | - |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -11.99M (+8.02%) | -11.10M (+34.87%) | -8.23M (+205.95%) | -2.69M (-81.44%) | -14.49M (-39.80%) | -24.07M (+155.79%) | -9.41M (-6.27%) | -10.04M (-20.51%) | -12.63M (+13.17%) | -11.16M (-18.30%) | -13.66M (-2.22%) | -13.97M (+5.83%) | -13.20M (+9.00%) | -12.11M (+4.76%) | -11.56M (-2.69%) | -11.88M (+1.28%) | -11.73M (+28.48%) | -9.13M (-19.91%) | -11.40M (-2.65%) | -11.71M (+19.25%) | -9.82M (+17.75%) | -8.34M (-12.76%) | -9.56M (+49.61%) | -6.39M (+24.56%) | -5.13M (-51.33%) | -10.54M (+311.72%) | -2.56M | - | - |
Ebit | -11.99M (+8.02%) | -11.10M (+34.87%) | -8.23M (+205.95%) | -2.69M (-81.44%) | -14.49M (-39.80%) | -24.07M (+155.79%) | -9.41M (-6.27%) | -10.04M (-20.51%) | -12.63M (+13.17%) | -11.16M (-18.30%) | -13.66M (-2.22%) | -13.97M (+5.83%) | -13.20M (+9.00%) | -12.11M (+4.76%) | -11.56M (-2.69%) | -11.88M (+1.28%) | -11.73M (+28.48%) | -9.13M (-19.91%) | -11.40M (-2.65%) | -11.71M (+19.25%) | -9.82M (+17.75%) | -8.34M (-12.76%) | -9.56M (+49.61%) | -6.39M (+24.56%) | -5.13M (+60.82%) | -3.19M (+24.61%) | -2.56M (-20.99%) | -3.24M (-21.36%) | -4.12M |
EBITDA | -11.73M (-0.34%) | -11.77M (+43.71%) | -8.19M (+301.47%) | -2.04M (-85.92%) | -14.49M (-43.82%) | -25.79M (+199.88%) | -8.60M (-5.49%) | -9.10M (-27.89%) | -12.62M (-8.62%) | -13.81M (+12.92%) | -12.23M (-3.70%) | -12.70M (-3.64%) | -13.18M (+6.89%) | -12.33M (+9.21%) | -11.29M (-4.89%) | -11.87M (+1.37%) | -11.71M (+28.26%) | -9.13M (-19.63%) | -11.36M (-2.99%) | -11.71M (+19.49%) | -9.80M (+16.81%) | -8.39M (-11.78%) | -9.51M (+49.76%) | -6.35M (+23.78%) | -5.13M (+60.82%) | -3.19M (+25.10%) | -2.55M (-21.30%) | -3.24M (-21.36%) | -4.12M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Interest Expense | 670K (+6600.00%) | 10K (-50.00%) | 20K (-33.33%) | 30K (-25.00%) | 40K (-33.33%) | 60K (-14.29%) | 70K (-12.50%) | 80K (-20.00%) | 100K (-9.09%) | 110K (-8.33%) | 120K (-7.69%) | 130K (0.00%) | 130K (0.00%) | 130K (+18.18%) | 110K (+22.22%) | 90K (0.00%) | 90K (0.00%) | 90K (0.00%) | 90K (+12.50%) | 80K (-11.11%) | 90K (+12.50%) | 80K (0.00%) | 80K (-11.11%) | 90K (+28.57%) | 70K (+16.67%) | 60K (+500.00%) | 10K | - | - |
Net Interest Income | -670.00K (+6600.00%) | -10.00K (-50.00%) | -20.00K (-33.33%) | -30.00K (-25.00%) | -40.00K (-33.33%) | -60.00K (-14.29%) | -70.00K (-12.50%) | -80.00K (-20.00%) | -100.00K (-9.09%) | -110.00K (-8.33%) | -120.00K (-7.69%) | -130.00K (0.00%) | -130.00K (0.00%) | -130.00K (+18.18%) | -110.00K (+22.22%) | -90.00K (0.00%) | -90.00K (0.00%) | -90.00K (0.00%) | -90.00K (+12.50%) | -80.00K (-11.11%) | -90.00K (+12.50%) | -80.00K (0.00%) | -80.00K (-11.11%) | -90.00K (+28.57%) | -70.00K (+16.67%) | -60.00K | - | - | - |
Other Non Operating Income | - | - | - | - | - | - | 810K (-13.83%) | 940K (-15.32%) | 1.11M | - | 1.42M (+11.81%) | 1.27M (+135.19%) | 540K | - | - | 100K (+66.67%) | 60K (-50.00%) | 120K (+200.00%) | 40K (+100.00%) | 20K (0.00%) | 20K (-90.00%) | 200K (+300.00%) | 50K (+25.00%) | 40K (0.00%) | 40K (-50.00%) | 80K (+300.00%) | 20K | - | - |
Net Income | |||||||||||||||||||||||||||||
Net Income From Continuing Operations | -12.27M (-16.25%) | -14.65M (+78.44%) | -8.21M (+296.62%) | -2.07M (-85.26%) | -14.04M (-40.41%) | -23.56M (+171.74%) | -8.67M (-5.56%) | -9.18M (-21.00%) | -11.62M (+16.78%) | -9.95M (-19.43%) | -12.35M (-3.67%) | -12.82M (+0.23%) | -12.79M (+14.81%) | -11.14M (-2.28%) | -11.40M (-3.96%) | -11.87M (+0.94%) | -11.76M (+28.10%) | -9.18M (-19.83%) | -11.45M (-2.72%) | -11.77M (+19.01%) | -9.89M (+18.59%) | -8.34M (-13.03%) | -9.59M (+48.68%) | -6.45M (+24.76%) | -5.17M (+62.58%) | -3.18M (+24.71%) | -2.55M (-21.30%) | -3.24M (-21.36%) | -4.12M |
Net Income | -12.27M (-16.25%) | -14.65M (+78.44%) | -8.21M (+296.62%) | -2.07M (-85.26%) | -14.04M (-40.41%) | -23.56M (+171.74%) | -8.67M (-5.56%) | -9.18M (-21.00%) | -11.62M (+16.78%) | -9.95M (-19.43%) | -12.35M (-3.67%) | -12.82M (+0.23%) | -12.79M (+14.81%) | -11.14M (-2.28%) | -11.40M (-3.96%) | -11.87M (+0.94%) | -11.76M (+28.10%) | -9.18M (-19.83%) | -11.45M (-2.72%) | -11.77M (+19.01%) | -9.89M (+18.59%) | -8.34M (-13.03%) | -9.59M (+48.68%) | -6.45M (+24.76%) | -5.17M (+62.58%) | -3.18M (+24.71%) | -2.55M (-21.30%) | -3.24M (-21.36%) | -4.12M |
Comprehensive Income Net Of Tax | - | - | - | - | - | -53.04M (+511.76%) | -8.67M (-5.56%) | -9.18M (-21.00%) | -11.62M (-75.46%) | -47.36M (+285.04%) | -12.30M (-3.07%) | -12.69M (+2.17%) | -12.42M (-73.32%) | -46.55M (+307.26%) | -11.43M (-4.91%) | -12.02M (-2.04%) | -12.27M (-71.12%) | -42.48M (+271.65%) | -11.43M (-3.14%) | -11.80M (+19.31%) | -9.89M (-66.52%) | -29.54M (+208.03%) | -9.59M (+48.68%) | -6.45M | - | - | - | - | - |